These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35958555)

  • 1. Hypoxia-Immune-Related Gene SLC19A1 Serves as a Potential Biomarker for Prognosis in Multiple Myeloma.
    Li W; Yuan P; Liu W; Xiao L; Xu C; Mo Q; Xu S; He Y; Jiang D; Wang X
    Front Immunol; 2022; 13():843369. PubMed ID: 35958555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC19A1 May Serve as a Potential Biomarker for Diagnosis and Prognosis in Osteosarcoma.
    Li C; Yuan B; Yu X; Ju L; Ma Y; Guo D; Zhang K
    Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma.
    Li L; Chen T; Wang J; Li M; Li Q
    J Immunol Res; 2022; 2022():3922739. PubMed ID: 35677537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of a Potential Prognostic 7-lncRNA Signature for Predicting Survival in Patients with Multiple Myeloma.
    Zhong Y; Liu Z; Li D; Liao Q; Li J
    Biomed Res Int; 2020; 2020():3813546. PubMed ID: 33204693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma.
    Zhao N; Qu C; Yang Y; Li H; Li Y; Zhu H; Long Z
    Sci Rep; 2023 Nov; 13(1):19395. PubMed ID: 37938654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
    Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
    J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma.
    Wang W; Xu SW; Zhu XY; Guo QY; Zhu M; Mao XL; Chen YH; Li SW; Luo WD
    Front Genet; 2021; 12():665173. PubMed ID: 33981333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-related gene signature for predicting LUAD patients' prognosis and immune microenvironment.
    Chen J; Fu Y; Hu J; He J
    Cytokine; 2022 Apr; 152():155820. PubMed ID: 35176657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.
    Hu AX; Huang ZY; Zhang L; Shen J
    Tumour Biol; 2017 Apr; 39(4):1010428317694563. PubMed ID: 28378636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DPA1 gene is a potential predictor with prognostic values in multiple myeloma.
    Yang J; Wang F; Chen B
    BMC Cancer; 2020 Sep; 20(1):915. PubMed ID: 32972413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Hypoxia-Associated Prognostic Signature Related to Osteosarcoma Metastasis and Immune Infiltration.
    Fu Y; Bao Q; Liu Z; He G; Wen J; Liu Q; Xu Y; Jin Z; Zhang W
    Front Cell Dev Biol; 2021; 9():633607. PubMed ID: 33816483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 18. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of hub genes with prognostic values in multiple myeloma by bioinformatics analysis.
    Yang J; Wang F; Zhong S; Chen B
    Hematology; 2021 Dec; 26(1):453-459. PubMed ID: 34165034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
    Zhang J; He P; Wang X; Wei S; Ma L; Zhao J
    Front Genet; 2021; 12():778715. PubMed ID: 34976013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.